Bioinspired affinity DNA polymers on nanoparticles for drug sequestration and detoxification

Biomaterials

Volumn 35, Issue 36, 2014, Pages 9709-9718

  Chen, Niancao ^a   Huang, Yike ^a   Wang, Yong ^a  

^a The Pennsylvania State University   (United States)

Author keywords

Affinity; Aptamer; DNA; Nanoparticle; Polymer

Indexed keywords

DETOXIFICATION; DNA; DRUG DELIVERY; MOLECULES; NANOPARTICLES; NANOSTRUCTURED MATERIALS; POLYMERS;

AFFINITY; APTAMERS; BIOLOGICAL EFFECTS; BROAD APPLICATION; COMPACT STRUCTURES; MOLECULAR TRANSPORT; SMALL-MOLECULE DRUGS; TARGET MOLECULE;

SYNTHESIS (CHEMICAL);

APTAMER; DNA; DOXORUBICIN; NANOMATERIAL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; THROMBIN; ANTINEOPLASTIC ANTIBIOTIC; HEMOSTATIC AGENT; NANOPARTICLE; POLYMER;

ARTICLE; BINDING AFFINITY; BLOOD CLOTTING TIME; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DNA INTERACTION; DRUG UPTAKE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NANOFABRICATION; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; CHEMISTRY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

SCYPHOZOA;

ANTIBIOTICS, ANTINEOPLASTIC; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; DNA; DOXORUBICIN; HEMOSTATICS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NANOPARTICLES; POLYMERS; THROMBIN;

EID: 84922386778     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.08.017     Document Type: Article

References (52)

1. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
2. Kesharwani P., Gajbhiye V., Jain N.K. Areview of nanocarriers for the delivery of small interfering RNA. Biomaterials 2012, 33:7138-7150.
3. Wang H., Zhou W., Yin X., Zhuang Z., Yang H., Wang X. Template synthesized molecularly imprinted polymer nanotube membranes for chemical separations. JAm Chem Soc 2006, 128:15954-15955.
4. Cao Y.C., Jin R., Mirkin C.A. Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science 2002, 297:1536-1540.
5. Liu J., Lu Y. Fast colorimetric sensing of adenosine and cocaine based on a general sensor design involving aptamers and nanoparticles. Angew Chem, Int 2006, vol. 45:90-94.
6. Gao X., Cui Y., Levenson R.M., Chung L.W.K., Nie S. Invivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
7. Chen N., Li S., Battig M.R., Wang Y. Programmable imaging amplification via nanoparticle-initiated DNA polymerization. Small 2013, 9:3944-3949.
8. Haun J.B., Devaraj N.K., Hilderbrand S.A., Lee H., Weissleder R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat Nanotechnol 2010, 5:660-665.
9. Dhanikula A.B., Khalid N.M., Lee S.D., Yeung R., Risovic V., Wasan K.M., et al. Long circulating lipid nanocapsules for drug detoxification. Biomaterials 2007, 28:1248-1257.
10. Hu C.-M.J., Fang R.H., Copp J., Luk B.T., Zhang L. Abiomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol 2013, 8:336-340.
11. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4:145-160.
12. Smith C., Shkumatov A., Withers S. Apolymeric fastener can easily functionalize liposome surfaces with gadolinium for enhanced magnetic resonance imaging. ACS Nano 2013, 7:9599-9610.
13. Wang Y., Gao S., Ye W.-H., Yoon H.S., Yang Y.-Y. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater 2006, 5:791-796.
14. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
15. Pan Y., Du X., Zhao F., Xu B. Magnetic nanoparticles for the manipulation of proteins and cells. Chem Soc Rev 2012, 41:2912-2942.
16. Hoshino Y., Kodama T., Okahata Y., Shea K.J. Peptide imprinted polymer nanoparticles: a plastic antibody. JAm Chem Soc 2008, 130:15242-15243.
17. Hoshino Y., Koide H., Urakami T., Kanazawa H., Kodama T., Oku N., et al. Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody. JAm Chem Soc 2010, 132:6644-6645.
18. Bateman D.N. Digoxin-specific antibody fragments: how much and when?. Toxicol Rev 2004, 23:135-143.
19. Jones C.M., Mack K.A., Paulozzi L.J. Pharmaceutical overdose deaths, United States, 2010. JAMA J Am Med Assoc 2013, 309:657-659.
20. Leroux J.C. Injectable nanocarriers for biodetoxification. Nat Nanotechnol 2007, 2:679-684.
21. Cai K., Li J., Luo Z., Hu Y., Hou Y., Ding X. β-Cyclodextrin conjugated magnetic nanoparticles for diazepam removal from blood. Chem Commun 2011, 47:7719-7721.
22. Mertz C.J., Kaminski M.D., Xie Y., Finck M.R., Guy S., Rosengart A.J. Invitro studies of functionalized magnetic nanospheres for selective removal of a simulant biotoxin. JMagn Magn Mater 2005, 293:572-577.
23. Aldaye F.A., Palmer A.L., Sleiman H.F. Assembling materials with DNA as the guide. Science 2008, 321:1795-1799.
24. Seeman N.C. DNA in a material world. Nature 2003, 421:427-431.
25. Fire A., Xu S.Q. Rolling replication of short DNA circles. Proc Natl Acad Sci U. S. A 1995, 92:4641-4645.
26. Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988, 239:487-491.
27. Dirks R.M., Pierce N.A. Triggered amplification by hybridization chain reaction. Proc Natl Acad Sci U S A 2004, 101:15275-15278.
28. Zadeh J.N., Steenberg C.D., Bois J.S., Wolfe B.R., Pierce M.B., Khan A.R., et al. NUPACK: analysis and design of nucleic acid systems. JComput Chem 2010, 32:170-173.
29. Letowski J., Brousseau R., Masson L. Designing better probes: effect of probe size, mismatch position and number on hybridization in DNA oligonucleotide microarrays. JMicrobiol Meth 2004, 57:269-278.
30. Gotoh M., Hasegawa Y., Shinohara Y., Shimizu M., Tosu M. Anew approach to determine the effect of mismatches on kinetic parameters in DNA hybridization using an optical biosensor. DNA Res 1995, 2:285-293.
31. Xu J., Fogleman E.A., Craig S.L. Structure and properties of DNA-based reversible polymers. Macromolecules 2004, 37:1863-1870.
32. Roche C.J., Thomson J.A., Crothers D.M. Site selectivity of daunomycin. Biochemistry 1994, 33:926-935.
33. Chaires J.B., Herrera J.E. Preferential binding of daunomycin to 5'ATCG and 5'ATGC sequences revealed by footprinting titration experiments. Biochemistry 1990, 29:6145-6153.
34. Tarasiuk J., Frézard F., Garnier-Suillerot A., Gattegno L. Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration. Biochim Biophys Acta 1989, 1013:109-117.
35. Tassa C., Shaw S.Y., Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 2011, 44:842-852.
36. Reddy L.H., Arias J.L., Nicolas J., Couvreur P. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 2012, 112:5818-5878.
37. Kaminski M.D., Rosengart A.J. Detoxification of blood using injectable magnetic nanospheres: a conceptual technology description. JMagn Magn Mater 2005, 293:398-403.
38. Shaw J.P., Kent K., Bird J., Fishback J., Froehler B. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res 1991, 19:747-750.
39. Verma S., Eckstein F. Modified oligonucleotides: synthesis and strategy for users. Annu Rev Biochem 1998, 67:99-134.
40. Eder P.S., DeVine R.J., Dagle J.M., Walder J.A. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. Antisense Res Dev 1991, 1:141-151.
41. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
42. Andrew D., Ellington J.W.S. Invitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
43. Wilson D.S., Szostak J.W. Invitro selection of functional nucleic acids. Annu Rev Biochem 1999, 68:611-647.
44. Wurm F.M. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 2004, 22:1393-1398.
45. Vicente T., Roldão A., Peixoto C., Carrondo M.J.T., Alves P.M. Large-scale production and purification of VLP-based vaccines. JInvertebr Pathol 2011, 107:S42-S48.
46. Sullivan D.H., Carter W.J., Warr W.R., Williams L.H. Side effects resulting from the use of growth hormone and insulin-like growth factor-I as combined therapy to frail elderly patients. JGerontol Ser A 1998, 53:M183-M187.
47. Vial T., Descotes J. Clinical toxicity of cytokines used as haemopoietic growth factors. Drug Saf 1995, 13:371-406.
48. Bock L.C., Griffin L.C., Latham J.A., Vermaas E.H., Toole J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992, 355:564-566.
49. Pasternak A., Hernandez F.J., Rasmussen L.M., Vester B., Wengel J. Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer. Nucleic Acids Res 2011, 39:1155-1164.
50. Weisel J., Shuman H., Litvinov R. Protein-protein unbinding induced by force: single-molecule studies. Curr Opin Struct Biol 2003, 13:227-235.
51. Farrance O.E., Hann E., Kaminska R., Housden N.G., Derrington S.R., Kleanthous C., et al. Aforce-activated trip switch triggers rapid dissociation of a colicin from its immunity protein. PLoS Biol 2013, 11. e1001489.
52. Jellinek D., Lynott C.K., Rifkin D.B., Janjić N. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci U. S. A 1993, 90:11227-11231.